Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 13;10(2):18.
doi: 10.3390/jdb10020018.

Craniofacial Phenotypes and Genetics of DiGeorge Syndrome

Affiliations
Review

Craniofacial Phenotypes and Genetics of DiGeorge Syndrome

Noriko Funato. J Dev Biol. .

Abstract

The 22q11.2 deletion is one of the most common genetic microdeletions, affecting approximately 1 in 4000 live births in humans. A 1.5 to 2.5 Mb hemizygous deletion of chromosome 22q11.2 causes DiGeorge syndrome (DGS) and velocardiofacial syndrome (VCFS). DGS/VCFS are associated with prevalent cardiac malformations, thymic and parathyroid hypoplasia, and craniofacial defects. Patients with DGS/VCFS manifest craniofacial anomalies involving the cranium, cranial base, jaws, pharyngeal muscles, ear-nose-throat, palate, teeth, and cervical spine. Most craniofacial phenotypes of DGS/VCFS are caused by proximal 1.5 Mb microdeletions, resulting in a hemizygosity of coding genes, microRNAs, and long noncoding RNAs. TBX1, located on chromosome 22q11.21, encodes a T-box transcription factor and is a candidate gene for DGS/VCFS. TBX1 regulates the fate of progenitor cells in the cranial and pharyngeal apparatus during embryogenesis. Tbx1-null mice exhibit the most clinical features of DGS/VCFS, including craniofacial phenotypes. Despite the frequency of DGS/VCFS, there has been a limited review of the craniofacial phenotypes of DGC/VCFS. This review focuses on these phenotypes and summarizes the current understanding of the genetic factors that impact DGS/VCFS-related phenotypes. We also review DGS/VCFS mouse models that have been designed to better understand the pathogenic processes of DGS/VCFS.

Keywords: 22q11.2 deletion syndrome; DiGeorge syndrome; cleft palate; cleidocranial dysplasia; hyoid bone; skull base; teeth abnormalities; velocardiofacial syndrome.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

Figure 1
Figure 1
Proximal deletions of chromosome 22q11.2 are responsible for the clinical features of DGS/VCFS. Snapshot of the UCSC Genome Browser (http://genome.ucsc.edu accessed on 3 August 2021) in the hg38 assembly showing the genomic context in the proximal deletions of chromosome 22q11.2. Top, the 25 kb resolution Hi-C data in H1 human embryonic stem cell line (H1-hESC). Bottom, the coding (blue) and noncoding RNAs (green), including miRNAs and long noncoding RNAs, are shown.
Figure 2
Figure 2
Interaction network of genes associated with DGS/VCFS phenotypes in mice. (A) A gene-based network where each gene connects to a feature. The network was constructed using ToppCluster (https://toppcluster.cchmc.org/ accessed on 6 May 2022). Mouse phenotypes are shown in the network. (B) The protein–protein interaction network was constructed using the STRING tool (https://string-db.org/ accessed on 6 May 2022). Genes associated with DGS/VCFS phenotypes in mice (Table 4) were the input. Different colors represent different types of evidence of a connection between proteins.

References

    1. Tézenas Du Montcel S., Mendizabai H., Aymé S., Lévy A., Philip N. Prevalence of 22q11 microdeletion. J. Med. Genet. 1996;33:719. doi: 10.1136/jmg.33.8.719. - DOI - PMC - PubMed
    1. Lopez-Rivera E., Liu Y.P., Verbitsky M., Anderson B.R., Capone V.P., Otto E.A., Yan Z., Mitrotti A., Martino J., Steers N.J., et al. Genetic Drivers of Kidney Defects in the DiGeorge Syndrome. N. Engl. J. Med. 2017;376:742–754. doi: 10.1056/NEJMoa1609009. - DOI - PMC - PubMed
    1. Du Q., de la Morena M.T., van Oers N.S.C. The Genetics and Epigenetics of 22q11.2 Deletion Syndrome. Front. Genet. 2019;10:1365. doi: 10.3389/fgene.2019.01365. - DOI - PMC - PubMed
    1. Gorlin R.J., Cohen M.M., Jr., Hennekam R.C.M. Syndromes of the Head and the Neck. Oxford University Press; New York, NY, USA: 2001. pp. 850–853.
    1. Yagi H., Furutani Y., Hamada H., Sasaki T., Asakawa S., Minoshima S., Ichida F., Joo K., Kimura M., Imamura S., et al. Role of TBX1 in human del22q11.2 syndrome. Lancet. 2003;362:1366–1373. doi: 10.1016/S0140-6736(03)14632-6. - DOI - PubMed

LinkOut - more resources